Weekly Rupiah Monitor: November 17–23, 2026 — Post-MSCI Freeze, Budget Anchors, and the Household Ledger

Rupiah Stability Watch · 2026-11-10

The premise

The week of November 17–23 opens with the MSCI November 11 decision behind us: Indonesia retains Emerging Market status, the Foreign Inclusion Factor stays frozen at 0.85, and the share-count freeze extends to December 1. The 2027 State Budget has been passed — IDR 4,100 trillion in spending, a 6% growth target, a 2.4% deficit anchor, and energy subsidies locked at IDR 261.5 trillion (with subsidized fuel volume trimmed to 19.56 million kiloliters). The DPR's MBG debate continues; the Budget Committee's proposed cap of IDR 174 trillion has not yet been finalized in plenary.

Against this backdrop, the rupiah screen shows JISDOR at 18,161 (November 2), within striking distance of the all-time high of 18,183 hit on October 28. Bank Indonesia reserves stand at USD 146.8 billion — the highest since March — covering 5.3 months of imports. Brent crude trades with a Hormuz risk premium; EIA's 2026 outlook sits at $87/bbl. Foreign capital has delivered USD 7.33 billion in net inflows year-to-date, but the composition tells the real story: SRBI (IDR 178.6 trillion) and SBN (IDR 36.7 trillion) absorb the inflows, while equities have seen IDR 84.2 trillion in outflows. The 10-year SBN yield eased to 7.56% on November 10; the spread against U.S. Treasuries has compressed to 188 basis points. Headline inflation came in at 3.23% YoY in October, within BI's 2.5±1% corridor, though volatile food inflation accelerated to 5.81% YoY. The November CPO reference price was cut 6.07% to USD 978.90/MT.

This monitor assembles the data box, reads the operating ledger beneath the screen, maps pressure across three channels, and translates what it means for four actors on the ground.

Data box: November 17–23 window (latest available)

Operating-ledger synthesis: what the screen doesn't show

1. The reserve accumulation is fiscal, not organic. The USD 0.5 billion month-on-month rise in October reserves came from government external loan withdrawals and global sukuk issuance — not from current-account surplus or sustained portfolio inflows. Debt service and BI intervention costs absorb a material share. The import-cover ratio (5.3 months) is adequate by IMF metrics but flattens once debt-service coverage is netted out.

2. SRBI inflows are a confidence proxy, not a capital-account solution. Short-tenor rupiah securities (SRBI) now hold the bulk of foreign inflows. They are reversible within days. A risk-off shift — Fed repricing, Hormuz escalation, or MSCI reclassification — would see SRBI redemptions accelerate before SBN or equity flows adjust. The concentration in one instrument creates a liquidity cliff the screen does not flag.

3. The equity bleed is structural while the freeze holds. MSCI's FIF freeze at 0.85 caps index weight regardless of fundamentals. Foreign equity outflows (IDR 84.2 T YTD) reflect forced underweighting by passive funds and active managers reducing EM sleeve exposure. The freeze extends to December 1; the next review window is the February 2027 Semi-Annual Index Review. Until then, equity flows are hostage to the index methodology, not Indonesian earnings.

4. The CPO price cut is a double-edged transmission. The 6.07% monthly drop in the reference price reduces export revenue (current account) but also lowers the domestic cooking-oil subsidy burden (fiscal). For a palm-oil exporter, the USD 63/MT drop on a November shipment of 10,000 MT is USD 630,000 in lost revenue — partially offset by a weaker rupiah if the pass-through holds. For the fiscal ledger, lower CPO prices ease the biodiesel (B40) and cooking-oil subsidy arithmetic.

5. Haze risk has receded but the El Niño signal persists. Singapore PSI eased to Moderate (51–55) by November 7; NEA ceased daily updates. ASMC downgraded regional alert to Level 1. However, the NDJ (Nov–Jan) outlook still calls for below-normal rainfall over southern Kalimantan and parts of Sumatra under strong El Niño conditions. A late-season flare-up would hit Sumatra and Kalimantan logistics — palm oil, coal, and rice transport — adding to volatile food inflation.

6. The MBG kitchen-status opacity remains a capital-account verification gap. As documented in prior monitors, the Free Nutritious Meal (MBG) program's kitchen-level reporting (BGN) has not produced auditable, verifiable disbursement data. MSCI's November 11 decision noted the freeze extension partly on "data transparency" grounds. Until BGN publishes kitchen-level financial and nutritional artifacts that survive third-party verification, this remains an open item in the capital-account conformance chain.

Three-channel pressure map

Current account: Moderate pressure, tilting negative

• Goods trade: CPO price decline (–6% MoM) and Brent at $87/bbl (Indonesia is a net oil importer) compress the trade surplus. Non-oil/gas exports weakening on global demand.
• Services: Travel surplus holds; transport deficit widens on higher freight rates (Hormuz reroute).
• Primary income: Debt-service outflows rising with reserve accumulation via external borrowing.
• Net: Current account likely slips to a small deficit in Q4 2026 after a modest surplus in H1. The 2027 budget assumes a manageable deficit; the risk is a wider gap if oil sustains above $90.

Capital account: Elevated pressure, concentrated and reversible

• Portfolio inflows: Strong headline (USD 7.33 bn YTD) but 85%+ in SRBI (short-tenor, reversible). SBN inflows positive but decelerating; 10Y spread compression limits further upside.
• MSCI freeze: FIF 0.85 caps passive equity inflows. Forced-selling risk low (status quo), but rebalancing risk high if freeze lifts in Feb 2027.
• Direct investment: FDI realization data lagging; greenfield announcements positive but realization rate ~60%.
• External debt: Government borrowing funding reserves; corporate rollover manageable but watch property and SOE maturity walls in 2027.
• Net: Capital account stays positive but fragile. A 10% SRBI redemption wave would absorb ~USD 1.1 bn in days — reserves can cover it, but the signal to markets would be sharp.

Confidence perimeter: Fraying at the household and verification layers

• Institutional: BI credibility intact (inflation in target, reserves adequate). Fiscal credibility anchored by passed budget but MBG execution risk unpriced.
• Market: MSCI freeze = known known. Feb 2027 review = known unknown. Hormuz = tail risk with $100+/bbl downside.
• Household: Volatile food at 5.81% YoY erodes real wages faster than headline CPI suggests. Transport costs up on fuel-price passthrough (subsidized volume cut). Medicine access strained by rupiah depreciation on import-dependent pharmaceuticals.
• Verification: BGN kitchen data gap persists. Budget execution chain conformance (commitment→disbursement→procurement→realization) untested at scale for 2027 anchors.

Impact reads: four actors, one week

Jakarta household (dual-income, two children, renting in East Jakarta)

• Rice + cooking oil + transport basket: Volatile food at 5.81% YoY means the weekly grocery bill is up ~IDR 45,000–60,000 vs November 2025. Subsidized cooking oil (Minyakita) availability patchy; market-price RBD palm olein up ~8% MoM despite lower CPO reference (distribution margins, rupiah pass-through).
• Transport: Pertalite/Pertamax unsubsidized prices unchanged, but subsidized quota cut (19.56 ML vs 20.09 ML) means more households buy at market price. A 20 km daily commute costs ~IDR 15,000/day more than six months ago.
• Medicine: Import-dependent generics (antibiotics, hypertension, diabetes) up 10–15% YoY on rupiah depreciation. BPJS formulary coverage lagging price adjustments.
• Net: Real disposable income contracting. The household feels the 3.23% headline CPI as 5–6% on the items they actually buy.

Palm-oil exporter (Sumatra-based, 50,000 MT/month capacity)

• Revenue hit: November CPO reference at USD 978.90 vs October USD 1,042.15 = –USD 63/MT. On 50,000 MT = –USD 3.15 mn / ~IDR 57 bn monthly revenue drop.
• Rupiah cushion: JISDOR 18,161 vs 18,000 budget assumption = +IDR 161/USD. Partially offsets USD price drop (50,000 MT × USD 63 × IDR 161 ≈ IDR 508 bn gain on conversion — but only if hedged or sold at spot).
• Export duty/levy: Duty $124, levy $122.36/MT — unchanged in USD terms, higher in rupiah terms.
• B40 mandate: Domestic biodiesel offtake at fixed price provides floor but margins compress.
• Net: November cash flow negative vs budget. Hedge book and rupiah conversion timing decide survival margin.

Regional hospital (Type B, West Kalimantan, 200 beds)

• Drug procurement: 70% of formulary import-dependent. Rupiah at 18,161 vs 17,500 (Jan 2026) = 3.8% cost increase. Budget fixed in IDR; real purchasing power down.
• Fuel & logistics: Generator diesel (non-subsidized) up ~12% YoY. Medical supply transport from Surabaya/Jakarta up on freight rates.
• MBG kitchen linkage: Hospital doubles as MBG distribution hub for 15 schools. Kitchen infrastructure funded but operational budget (gas, staff, QA) not yet disbursed — BGN verification gap hits here directly.
• Patient load: Respiratory cases up 18% MoM (haze tail, seasonal). BPJS reimbursement rates unchanged since 2024.
• Net: Operating deficit widening. Capital expenditure (equipment replacement) deferred. MBG kitchen role adds mandate without funded ops.

Foreign portfolio manager (EM-dedicated fund, USD 2.5 bn AUM, 4% Indonesia overweight)

• MSCI freeze: FIF 0.85 means max theoretical weight capped. Current position at 3.8% (vs 4.2% benchmark) — underweight forced by index, not conviction.
• SRBI position: USD 120 mn in 1–3M SRBI at 6.2% yield (hedged). Carry positive but liquidity risk: 3-day settlement, no secondary market depth.
• SBN position: USD 80 mn in 10Y at 7.56% (188 bps spread). Spread compression limits total return; duration risk if BI hikes or Fed reprices.
• Equity: USD 40 mn in IHSG large-caps (banks, telecom). MSCI freeze = no passive bid. Earnings yield attractive (12x PE) but exit liquidity thin.
• Hormuz hedge: Long Brent call spreads (Dec $90/$100) — cost 1.2% of Indonesia sleeve. Tail hedge, not core view.
• Decision framework: Hold SRBI/SBN carry. Reduce equity to 2.5% (benchmark-neutral) until Feb 2027 review clarity. Size SRBI to max 5-day redemption buffer. Watch BGN verification artifacts — any credible kitchen-level data release = marginal positive for reclassification odds.

Watchlist: November 17–23 — concrete observables

What I'm uncertain about

1. SRBI redemption velocity under stress. We have no live stress-test data. The 2020 COVID episode saw ~IDR 30 T weekly outflows from SBN; SRBI did not exist then. The instrument's behavior in a genuine risk-off is unobserved.
2. BGN verification timeline. The "14-day window" post-MSCI has closed. No kitchen-level artifact has been published. The next MSCI touchpoint is February 2027. Whether BGN produces verifiable data before then is a binary unknown with asymmetric downside.
3. Hormuz escalation probability. The 2 mbpd flow is a fraction of pre-crisis. A single tanker incident could close the strait entirely. EIA's $87/bbl assumes current constraints; a full closure scenario ($120+/bbl) is not in the 2027 budget oil assumption (ICP ~$82).
4. Household medicine access granularity. BPJS formulary price adjustments lag market by 6–12 months. The actual stock-out rate for import-dependent generics in Type B/C hospitals outside Java is not publicly tracked.
5. DPR budget execution conformance. The budget is passed; the execution chain (commitment→disbursement→procurement→realization) has not been stress-tested at the 2027 scale. The Unified Remediation Tracker's 14 milestones are the leading indicator — watch Milestone 3 (Treasury Single Account integration) and Milestone 8 (E-procurement mandatory threshold).

The screen shows a rupiah holding near its weakest-ever level, reserves at a 2026 high, and capital inflows that look healthy in aggregate. The ledger shows those inflows are short-tenor and reversible, the reserve rise is debt-financed, the equity channel is structurally blocked by an index methodology freeze, and the household basket is inflating at nearly twice the headline rate. The coming week tests whether the budget anchors hold, whether BGN produces a verification artifact, and whether Hormuz stays a background risk or becomes the foreground shock.